Gary D. Steinberg, MD, is a Professor of Urology at Rush University, where he specializes in surgical oncology and genitourinary cancers. His research focuses on bladder cancer, particularly non-muscle-invasive disease, BCG-unresponsive carcinoma in situ, and emerging intravesical therapies. He leads pivotal trials, including the Phase 3 BOND-003 study of cretostimogene grenadenorepvec, and has published extensively on cost-effectiveness analyses, molecular landscapes, and global treatment patterns in high-risk bladder cancer. His work bridges clinical trial innovation, patient perspectives, and real-world outcomes, shaping contemporary standards in bladder cancer care.
See moreHonors

Experiences

Education
